142 related articles for article (PubMed ID: 7934429)
1. Is the timing of withdrawal bleeding a guide to endometrial safety during sequential oestrogen-progestagen replacement therapy? UK Continuous Combined HRT Study Investigators.
Sturdee DW; Barlow DH; Ulrich LG; Wells M; Gydesen H; Campbell M; O'Brien K; Vessey M
Lancet; 1994 Oct; 344(8928):979-82. PubMed ID: 7934429
[TBL] [Abstract][Full Text] [Related]
2. The endometrial response to sequential and continuous combined oestrogen-progestogen replacement therapy.
Sturdee DW; Ulrich LG; Barlow DH; Wells M; Campbell MJ; Vessey MP; Nielsen B; Anderson MC; Bragg AJ
BJOG; 2000 Nov; 107(11):1392-400. PubMed ID: 11117768
[TBL] [Abstract][Full Text] [Related]
3. [HRT in post-menopausal women: endometrial histology and bleeding patterns].
Lo Dico G; Alongi G; Spinelli MP; Cannariato P; Lucido AM
Minerva Ginecol; 2002 Aug; 54(4):361-6. PubMed ID: 12114870
[TBL] [Abstract][Full Text] [Related]
4. Sequential combined transdermal and oral postmenopausal hormone replacement therapies: effects on bleeding patterns and endometrial histology.
Sendag F; Terek MC; Karadadas N
Arch Gynecol Obstet; 2001 Nov; 265(4):209-13. PubMed ID: 11789748
[TBL] [Abstract][Full Text] [Related]
5. Hormone replacement therapy in postmenopausal women: endometrial hyperplasia and irregular bleeding.
Lethaby A; Farquhar C; Sarkis A; Roberts H; Jepson R; Barlow D
Cochrane Database Syst Rev; 2000; (2):CD000402. PubMed ID: 10796715
[TBL] [Abstract][Full Text] [Related]
6. Endometrial response in estrogen replacement therapy quarterly combined with a progestogen.
Boerrigter PJ; van de Weijer PH; Baak JP; Fox H; Haspels AA; Kenemans P
Maturitas; 1996 May; 24(1-2):63-71. PubMed ID: 8794436
[TBL] [Abstract][Full Text] [Related]
7. Can endometrial protection be inferred from the bleeding pattern on combined cyclical hormone replacement therapy.
Burch D; Bieshuevel E; Smith S; Fox H
Maturitas; 2000 Feb; 34(2):155-60. PubMed ID: 10714910
[TBL] [Abstract][Full Text] [Related]
8. Endometrial morphology and bleeding patterns as a function of progestogen supplementation.
Sturdee DW
Int J Fertil Menopausal Stud; 1996; 41(1):22-8. PubMed ID: 8673153
[TBL] [Abstract][Full Text] [Related]
9. Endometrial cancer and hormone-replacement therapy in the Million Women Study.
Beral V; Bull D; Reeves G;
Lancet; 2005 Apr 30-May 6; 365(9470):1543-51. PubMed ID: 15866308
[TBL] [Abstract][Full Text] [Related]
10. Effect on endometrium of long term treatment with continuous combined oestrogen-progestogen replacement therapy: follow up study.
Wells M; Sturdee DW; Barlow DH; Ulrich LG; O'Brien K; Campbell MJ; Vessey MP; Bragg AJ
BMJ; 2002 Aug; 325(7358):239. PubMed ID: 12153918
[TBL] [Abstract][Full Text] [Related]
11. Regression of endometrial thickness in combination with reduced withdrawal bleeding as a progestational effect of tibolone in postmenopausal women on oestrogen replacement therapy.
Meuwissen JH; Wiegerinck MA; Haverkorn MJ
Maturitas; 1995 Feb; 21(2):121-5. PubMed ID: 7752949
[TBL] [Abstract][Full Text] [Related]
12. Hormone replacement therapy and the endometrium.
Feeley KM; Wells M
J Clin Pathol; 2001 Jun; 54(6):435-40. PubMed ID: 11376015
[TBL] [Abstract][Full Text] [Related]
13. The uterus and the menopause.
Rees MC
Baillieres Clin Obstet Gynaecol; 1996 Sep; 10(3):419-32. PubMed ID: 8931903
[TBL] [Abstract][Full Text] [Related]
14. Disturbances of endometrial bleeding with hormone replacement therapy.
Thomas AM; Hickey M; Fraser IS
Hum Reprod; 2000 Aug; 15 Suppl 3():7-17. PubMed ID: 11041216
[TBL] [Abstract][Full Text] [Related]
15. Risk of endometrial cancer in relation to use of oestrogen combined with cyclic progestagen therapy in postmenopausal women.
Beresford SA; Weiss NS; Voigt LF; McKnight B
Lancet; 1997 Feb; 349(9050):458-61. PubMed ID: 9040575
[TBL] [Abstract][Full Text] [Related]
16. Bleeding patterns and endometrial histology during administration of low-dose estradiol sequentially combined with dydrogesterone.
van de Weijer PH; Scholten PC; van der Mooren MJ; Barentsen R; Kenemans P
Climacteric; 1999 Jun; 2(2):101-9. PubMed ID: 11910662
[TBL] [Abstract][Full Text] [Related]
17. No increased risk of endometrial hyperplasia with fixed long-cycle oestrogen-progestogen therapy after five years.
Erkkola R; Kumento U; Lehmuskoski S; Mattila L; Mustonen M
J Br Menopause Soc; 2004 Mar; 10(1):9-13. PubMed ID: 15107205
[TBL] [Abstract][Full Text] [Related]
18. Hormonal replacement regimens and bleeding.
Dören M
Maturitas; 2000 Jan; 34 Suppl 1():S17-23. PubMed ID: 10759060
[TBL] [Abstract][Full Text] [Related]
19. Unexpected vaginal bleeding and associated gynecologic care in postmenopausal women using hormone replacement therapy: comparison of cyclic versus continuous combined schedules.
Ettinger B; Li DK; Klein R
Fertil Steril; 1998 May; 69(5):865-9. PubMed ID: 9591494
[TBL] [Abstract][Full Text] [Related]
20. Comparison of a transdermal continuous combined and an interrupted progestogen HRT.
Cameron ST; Glasier AF; Gebbie A; Dewart H; Baird DT
Maturitas; 2006 Jan; 53(1):19-26. PubMed ID: 16325020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
